Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 4/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10534561 | 0.98 | NAAA (0.55) | NAAAEPHX2NPSR1MAPTMAPK1 | |
| SCHEMBL27270392 | 0.98 | NAAA (0.55) | NAAAEPHX2NPSR1MAPTMAPK1 | |
| SCHEMBL27274532 | 0.98 | NAAA (0.55) | NAAAEPHX2NPSR1MAPTMAPK1 | |
| SCHEMBL27272547 | 0.98 | NAAA (0.55) | NAAAEPHX2NPSR1MAPTMAPK1 | |
| SCHEMBL22125281 | 0.98 | NAAA (0.53) | NAAAEPHX2NPSR1MAPTMAPK1 | |
| SCHEMBL163813 | 0.95 | SMN1; SMN2 (0.47) | NAAAEPHX2L3MBTL1SMN1; SMN2 | |
| SCHEMBL22346246 | 0.95 | SMN1; SMN2 (0.47) | NAAAEPHX2L3MBTL1SMN1; SMN2 | |
| Acetic Acid SCHEMBL8962486 | 0.90 | ALDH1A1 (0.44) | NAAAEPHX2L3MBTL1SMN1; SMN2 | |
| SCHEMBL11838726 | 0.89 | NAAA (0.60) | NAAANPSR1RAD52FAAHDGKA | |
| SCHEMBL11829337 | 0.89 | NAAA (0.60) | NAAANPSR1RAD52FAAHDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140227201-A1 | Antimicrobial Gel Formulations | NOVABAY PHARMACEUTICALS, INC. | 2014-08-14 | — | — | US | claimed |
| US-8609600-B2 | Encapsulation of bulky fragrance molecules | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-12-17 | — | — | US | claimed |
| JP-2012500209-A | — | — | 2012-01-05 | — | — | JP | claimed |
| EP-2312939-A1 | ANTIMICROBIAL GEL FORMULATIONS | NovaBay Pharmaceuticals, Inc. (US) | 2011-04-27 | — | — | EP | claimed |
| US-20100076089-A1 | ANTIMICROBIAL GEL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. | 2010-03-25 | — | — | US | claimed |
| WO-2010019723-A1 | ANTIMICROBIAL GEL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. (US) | 2010-02-18 | — | — | WO | claimed |
| US-6844302-B1 | Encapsulated flavor and fragrance | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-18 | — | — | US | claimed |
| EP-1021511-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | Bush Boake Allen Inc. (US) | 2000-07-26 | — | — | EP | claimed |
| US-5972864-A | BLEACHING BLOCK; MIXTURE OF BLEACH AND ORGANOLEPTIC COMPOUND | LONZA INC. (US) | 1999-10-26 | — | — | US | claimed |
| US-5942153-A | A SHAPED STABLE BLOCK COMPRISING AN ORGANOLEPTIC FRAGRANT AGENT AND BLEACHING AGENT; FRAGRANT AGENT DOES NOT DECOMPOSE THE BLEACHING AGENT, NOT HYGROSCOPIC; USE IN VENTILATING HOOD AS PROTECTIVE GLOVES, A DUST MASK, AND GOGGLES | BUSH BOAKE ALLEN INC. (US) | 1999-08-24 | — | — | US | claimed |
| EP-0622451-B1 | Perfumed hypochlorite bleaching compositions | PROCTER & GAMBLE (US) | 1998-12-02 | — | — | EP | claimed |
| EP-0867503-A2 | Perfumed hypochlorite bleaching compositions | THE PROCTER & GAMBLE COMPANY (US) | 1998-09-30 | — | — | EP | claimed |
| WO-1998006804-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | BUSH BOAKE ALLEN INC. (US) | 1998-02-19 | — | — | WO | claimed |
| WO-2025242899-A1 | SUBSTITUTED CINNAMIC ACID DERIVATIVES AS UV ABSORBERS AND USES THEREOF | BASF SE (DE) | 2025-11-27 | — | — | WO | disclosed |
| EP-4398992-A1 | SUNSCREEN OR DAILY CARE COMPOSITION COMPRISING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND INORGANIC UV FILTERS | BASF SE (DE) | 2024-07-17 | — | — | EP | disclosed |
| WO-2023134886-A1 | SKIN MICROBIOME FRIENDLY SUNSCREENS | BASF SE (DE) | 2023-07-20 | — | — | WO | disclosed |
| EP-0867503-A2 | Perfumed hypochlorite bleaching compositions | THE PROCTER & GAMBLE COMPANY (US) | 1998-09-30 | — | — | EP | disclosed |
| WO-1998036049-A1 | BLEACHING AND CLEANING COMPOSITIONS CONTAINING FRAGRANCES | LONZA INC. (US) | 1998-08-20 | — | — | WO | disclosed |
| WO-1998006804-A1 | STABLE FRAGRANCES FOR BLEACHING COMPOUNDS | BUSH BOAKE ALLEN INC. (US) | 1998-02-19 | — | — | WO | disclosed |
| EP-0622451-A1 | Perfumed hypochlorite bleaching compositions | THE PROCTER & GAMBLE COMPANY (US) | 1994-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140227201-A1 | Antimicrobial Gel Formulations | CUTA, TUBA3C, POLR1C | NAAA 25/4885EPHX2 1694/4885NPSR1 2169/4885 |
| US-20100076089-A1 | ANTIMICROBIAL GEL FORMULATIONS | CUTA, TUBA3C, POLR1C | NAAA 25/4885EPHX2 1694/4885NPSR1 2169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.